# US 2019/0099517 A1 · Skin-adhesive silicone gel

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0099517 A1
- Document ID: US20190099517A1
- Status: Published application
- Kind: A1
- Application number: 16/086,000
- Filed: 2017-03-16
- Published: 2019-04-04
- Earliest claimed: 2016-03-17
- Assignees: Elkem Silicones France SAS
- Applicants: Elkem Silicones France SAS
- Inventors: Caroline MOINE; Maryline QUEMIN; Gaelle CROS
- Web page: https://patentgrep.com/patent/US20190099517A1

## CPC

- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 15/26: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}
- A61L 15/585: {Mixtures of macromolecular compounds}
- A61L 24/043: {Mixtures of macromolecular materials}
- A61L 26/0019: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds}
- A61L 27/34: Macromolecular materials
- C08K 5/56: Organo-metallic compounds, i.e. organic compounds containing a metal-to-carbon bond
- C08L 83/00: Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
- C08L 83/04: Polysiloxanes
- C09J 183/04: Polysiloxanes
- C08G 77/12: containing silicon bound to hydrogen
- C08G 77/20: containing silicon bound to unsaturated aliphatic groups
- C08L 75/04: Polyurethanes
- C08L 2203/02: for biomedical use
- C08L 2205/025: containing two or more polymers of the same hierarchy C08L, and differing only in parameters such as density, comonomer content, molecular weight, structure
- C08L 2205/03: containing three or more polymers in a blend
- C08L 2312/00: Crosslinking
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- C09J: ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES (preparation of glue or gelatine C09H)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

Silicone gels are described that are adhesive to the skin. The gels can be used in particular for articles that are adhesive to the skin for medical or paramedical use.

## Claims

### Claim 1

A silicone composition A which is a precursor of a silicone gel G and which is crosslinkable by hydrosilylation, the silicone composition A comprising:
1) at least one organopolysiloxane B comprising:
(i) at least two siloxyl units of formula (B1):
(Y)a(Z)bSiO(4-(a+b)/2 (B1)
in which:
Y represents a monovalent radical containing from 2 to 6 carbon atoms, having at least one alkenyl group,
Z represents a monovalent radical containing from 1 to 20 carbon atoms and not comprising an alkenyl group;
a and b represent integers, a being 1, 2 or 3, b being 0, 1 or 2 and (a+b) being 1, 2 or 3;
(ii) and optionally comprising other siloxyl units of formula (B2):
(Z)cSiO(4-c)/2 (B2)
in which:
Z has the same meaning as above, and
c represents an integer which is 0, 1, 2 or 3,
2) at least one organopolysiloxane CE comprising:
two siloxyl end units, which are identical or different, of formula (CE-1):
(H)p(R1)qSiO1/2 (CE-1)
in which:
the symbol R1 corresponds to a C1 to C8 alkyl group or to a C6 to C10 aryl group;
and the symbol H represents a hydrogen atom, with p=0 or 1, q=2 or 3 and (p+q)=3;
at least one siloxyl unit of formula (CE-2):
(H)n(R2)mSiO2/2 (CE-2)
in which the radical R2 corresponds to a C1 to C8 alkyl group or a C6 to C10 aryl group, the symbol H represents a hydrogen atom and with n=0 or 1, m=1 or 2 and (n+m)=2, and
with the condition according to which the organopolysiloxane CE contains two hydrogen atoms each one bonded to a different silicon atom per polymer;
3) at least one organopolysiloxane XL comprising:
at least three siloxy units of formula (XL-1):
(H) (L)e SiO(3-e)/2 (XL-1)
in which the symbol H represents a hydrogen atom, the symbol L represents an alkyl having from 1 to 8 carbon atoms inclusive or a C6 to C10 aryl, and the symbol e is equal to 0, 1 or 2; and
optionally other siloxy units of formula (XL-2):
(L)g SiO(4-g)/2 (XL-2)
in which the symbol L represents an alkyl having from 1 to 8 carbon atoms inclusive or a C6 to C10 aryl and the symbol g is equal to 0, 1, 2 or 3, and
with the condition according to which the organopolysiloxane XL contains from 15.1% to 40.0% by weight of Si—H function per polymer,
4) an effective amount of at least one hydrosilylation catalyst E,
5) at least one hydrosilylation reaction inhibitor D,
6) optionally at least one additive K, and
the weight amounts of the organopolysiloxanes B, CE and XL are chosen so as to satisfy the following three conditions:
a) the molar ratio RHAlk=tH/tAlk≥3.0;
b) the molar ratio RHCEV=nHCE/tAlk≥4.50, and
c) the mol % RHCE=(nHCE/tH)×100 is greater than or equal to 90 mol %, with:
tH=number of moles of hydrogen atom directly bonded to a silicon atom of the organopolysiloxanes CE and XL,
tAlk=number of moles of alkenyl directly bonded to a silicon atom of the organopolysiloxane B; and
nHCE=number of moles of hydrogen atom directly bonded to a silicon atom of the organopolysiloxane CE.

### Claim 2 (depends on 1)

The silicone composition A as claimed in claim 1, wherein:
the organopolysiloxane B has a dynamic viscosity at 25° C. of from 100 mPa.s to 120 000 mPa.s,
the organopolysiloxane CE has a dynamic viscosity at 25° C. of from 1 mPa.s to 500 m Pa.s, and
the organopolysiloxane XL has a dynamic viscosity at 25° C. of from 5 mPa.s to 2000 m Pa.s.

### Claim 3 (depends on 2)

The silicone composition A as claimed in claim 2, wherein the nature and the weight amounts of the organopolysiloxanes B, CE and XL are chosen such that the dynamic viscosity at 25° C. of the silicone composition X is from 200 mPa.s to 100 000 m Pa.s.

### Claim 4 (depends on 1)

The silicone composition A as claimed in claim 1, wherein the composition comprises at least two organopolysiloxanes B comprising, per molecule, at least two C2 to C6 alkenyl radicals each bonded to a silicon atom, the first having a dynamic viscosity at 25° C. of from 50 000 mPa.s to 120 000 mPa.s, and the second having a dynamic viscosity at 25° C. of from 500 mPa.s to 20 000 mPa.s.

### Claim 5 (depends on 1)

A silicone gel G obtained by crosslinking of the composition A as defined in claim 1, optionally by heating at a temperature of from 70° C. to 200° C. and/or under the action of infrared radiation.

### Claim 6 (depends on 5)

The silicone gel G as defined in claim 5, wherein the gel is in a medical device selected from the group consisting of a mammary prosthesis, an adhesive dressing that adheres to the skin or a device for holding in place medical accessories used in contact with the skin, of sensor, probe, catheter and needle type.

### Claim 7 (depends on 5)

An item which adheres to the skin, the item comprising a substrate S which is a plastic film, optionally a polyester or polyurethane film, continuously or discontinuously coated onto at least one of the two faces with a silicone gel G as claimed in claim 5.

### Claim 8 (depends on 7)

The item as claimed in claim 7, wherein the substrate S is a perforated flexible polyurethane film or a continuous flexible polyurethane film.

### Claim 9 (depends on 7, 8)

A dressing or patch for medical or paramedical use, the dressing or patch that comprising an item that adheres to the skin as described in claim 7 or 8.

### Claim 10 (depends on 5)

A mammary prosthesis comprising a polyurethane pouch comprising the silicone gel G as defined in claim 5.

### Claim 11 (depends on 5)

A cushion or mattress for minimizing pressure sores, the cushion or mattress comprising the silicone gel G as defined in claim 5.

### Claim 12 (depends on 1)

The silicone composition A as claimed in claim 1, wherein the polyorganosiloxane CE contains, per polymer, and preferably the organopolysiloxane CE contains, per polymer, two siloxyl units of formula (CE-1) in which p=1 and at least one siloxyl unit of formula (CE-2) in which n=0.

### Claim 13 (depends on 1)

The silicone composition A as claimed in claim 1, wherein organopolysiloxane XL has from 18% to 35.0% by weight of Si—H function per polymer.

### Claim 14 (depends on 1)

The silicone composition A as claimed in claim 1, wherein the molar ratio is 3.0≤RHAlk≤24.

### Claim 15 (depends on 14)

The silicone composition A as claimed in claim 14, wherein the molar ratio is 4.50≤RHAlk≤20.

### Claim 16 (depends on 1)

The silicone composition A as claimed in claim 1, wherein the molar ratio is 4.50≤RHCEV≤20.

### Claim 17 (depends on 1)

The silicone composition A as claimed in claim 1, wherein the mol % RHCE=(nHCE/+H)×100 is from 90 mol % to 95 mol %.

### Claim 18 (depends on 1)

The silicone composition A as claimed in claim 1, wherein CE has a dynamic viscosity at 25° C. of from 5 to 200 mPa.s.

### Claim 19 (depends on 1)

The silicone composition A as claimed in claim 1, wherein XL has a dynamic viscosity at 25° C. from 5 to 500 mPa.s.

### Claim 20 (depends on 2)

The silicone composition A claim 2, wherein the dynamic viscosity of silicone composition X is from 200 mPa.s. to 80,000 mPa.s.
